| |
|
|
Boryung Pharmaceutical (003850) |
|
|
STOCK |
|
|
| Address |
BORYUNG BLDG., 66-21, WONNAM-DONG, JONGNO-GU, SEOUL |
| Home Page |
www.boryung.co.kr
|
| Established |
1963.11.11 |
Tel |
02-708-8000 |
| Listed |
1988.10.24 |
IR |
02-708-8086 |
| Common shares O/S |
2,960,000 |
President |
Kim,Seung Ho/Kim,Gwang Ho |
| Preferred shares O/S |
|
No.of Employees |
884(2008. 3) |
| Sales posted a steady growth on increased sales of its mainstay products. Its profitability improved on increased sales at home and improved operating income. The company is seeking to diversify its revenue sources by developing new drugs and investing in ventures. |
| The company's profitability is expected to improve on business restructuring and rising demand for new drugs. Demand for specialized drugs is expected to rise and sales of ETC are also expected to increase. The company is expected to benefit by selling its real estates. |
|
  |
(date: 2007.12, unit : %) |
| Name |
BORYUNG |
GMO |
Boryung Medience |
| Portion |
18.8 |
11.0 |
9.6 |
|
 |
(unit : %) |
| Sales |
Cinalong |
8.6 |
Cost |
Raw Materials |
68.9 |
| Gelpos M |
8.1 |
Labors |
12.8 |
|
|
Overhead |
18.2 |
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
01. 4 |
04. 4 |
06. 4 |
07. 4 |
08. 4 |
| Type |
SD |
SD |
SD |
SD |
SD |
| Amount |
3.00 |
3.00 |
3.00 |
3.00 |
3.00 |
|
|
|
|
